drugset / Trial / NCT01660386

Study of Comparing the Different Effect of DPP-4 Inhibitors and Sulfonylurea by Using "Biphase-Hyperglycemic Clamp"

NCT01660386

RandomizedCrossoverOpen-label

Summary

The objective of this study is to demonstrate the different effects of two DPP-4 inhibitors(Sitagliptin, Saxagliptin)and the insulin secretagogue: glimepiride on first and second phase insulin secretion by using a Biphase-Hyperglycemic Clamp and to explore the different effects of the study drugs on the GLP-1 response, and the glucagon concentration which indicates alpha cell function in healthy subjects.

Timeline

Start
2012-07
Primary completion
2012-12
Completion
2013-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Glimepiride Small molecule 2 mg Oral
Subject SAXAGLIPTIN ANHYDROUS Small molecule 5 mg Oral
Subject Sitagliptin Small molecule 100 mg Oral